Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree
Windtree Therapeutics has not been shy about its desire to become a revenue-generating company, even when achieving that goal meant stepping outside the world of drug development. Now, the company is ...
WARRINGTON, PA — Windtree Therapeutics, Inc. (OTCID: WINT) said it has agreed to sell its cardiovascular drug candidates to Seismic Pharmaceutical Holdings, LLC, a private investment group, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results